Admerus Biosciences Private Limited

Admerus Biosciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74900TG2015PTC133392 Incorporated 09 July 2015 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹12.8 Cr
▼ 43% YoY
Net loss · FY 2024
₹74,170
Net margin -0.1%
EBITDA · FY 2024
₹5.85 Cr
EBITDA margin 45.7%
Authorised capital
₹14 Cr
Registered with MCA
Paid-up capital
₹11.93 Cr
Issued & subscribed
Open charges
₹4.32 Cr
Satisfied ₹20.95 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
19
Provident fund records

About Admerus Biosciences Private Limited

Data last updated:

Admerus Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 09 July 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2015PTC133392. Its GSTIN is 36AANCA5988K1ZU (Telangana).

The company has an authorised share capital of ₹14 Cr and a paid-up capital of ₹11.93 Cr. It is led by directors including Pattabhi Ram Koppineedi (Managing Director) and Jayasree Koppineedi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Survey No 478 And 480 Basuregadi Village Gowdavelly Grama Panchayath, Hyderabad, Telangana, India – 501401.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.8 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹74,170 (net margin -0.1%) and EBITDA of ₹5.85 Cr (EBITDA margin 45.7%). Revenue has grown at a compounded annual rate (CAGR) of 238% over five years.

The company has about 19 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Admerus. As per MCA filings, the company has open charges of ₹4.32 Cr and satisfied charges of ₹20.95 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 3 cases are pending. The company has 8 deals on record (4 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.22 Cr; the latest was in December 2022.

Admerus Biosciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0031652). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website admerus.com.

Company details

CIN U74900TG2015PTC133392
Registration Number 133392
Incorporation Date 09 July 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0031652

CIN history

Admerus Biosciences has one previous CIN (Corporate Identification Number): U74900AP2015PTC096962. The current CIN is U74900TG2015PTC133392, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74900TG2015PTC133392Current
U74900AP2015PTC096962Previous
Key People
Pattabhi Ram Koppineedi Managing Director Jayasree Koppineedi Director China Gangaiah Koppineedi Director

Recognitions & Rankings of Admerus Biosciences

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0031652

Contact details

Admerus Biosciences Private Limited's registered office is in Hyderabad, Telangana. Its website is admerus.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    admerus.com
  • Social Media
  • Registered Address
    Survey No 478 And 480 Basuregadi Village Gowdavelly Grama Panchayath, Hyderabad, Telangana, India – 501401
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Admerus Biosciences Private Limited, buy the company report.

Comprehensive company report
Admerus Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Admerus Biosciences operates one associated brand: Admerus. Each brand links to its own profile.

BrandDescriptionWebsite
Admerus
Provides contract research and development services for global biopharma programs.admerus.com

Business activity

The main business activity of Admerus Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Admerus Biosciences Private Limited, buy the company report.

Financials of Admerus Biosciences Private Limited

FY 2024 filings available

Admerus Biosciences Private Limited reported revenue of ₹12.8 Cr (down 43% YoY) for FY 2024.

Revenue · FY 2024
₹12.8 Cr ▼ 43%
Net loss · FY 2024
₹74,170 margin -0.1%
EBITDA · FY 2024
₹5.85 Cr margin 45.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 43%
5 years · compounded
▲ 238%
EBITDA CAGR growth
1 year
▼ 16%
5 years · compounded
▲ 216%

Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 238%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.85 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹74,170
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin45.7%
Net Profit Margin-0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Admerus Biosciences Private Limited, buy the company report.

Board of directors of Admerus Biosciences Private Limited

Admerus Biosciences has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jayasree KoppineediDirector07 Oct 20179 Years 0 MonthsCurrent
China Gangaiah Koppineedi
Also directs: Organic Harvests Private Limited
Director09 Jul 201511 Years 3 MonthsCurrent
Pattabhi Ram Koppineedi
Also directs: Organic Harvests Private Limited
Managing Director09 Jul 201511 Years 3 MonthsCurrent
View all directors

Auditor

Admerus Biosciences Private Limited is audited by Kommula & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Kommula & CoFY 2023015628S

Shareholding

The shareholding of Admerus Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Admerus Biosciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.32 Cr
Satisfied charges
₹20.95 Cr
Breakdown by lending institutions
State Bank of India₹4.32 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 May 2025101097818State Bank of India₹4.32 CrOpen
17 Nov 2017100185075State Bank of India₹20.95 CrSatisfied

To see the full charge records of Admerus Biosciences Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Admerus Biosciences Private Limited has 8 deals on record (4 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.22 Cr; the latest was in December 2022.

Total deals
8
Rights issues
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹3.22 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Dec 2022Funding round₹1 CrInvestors: 2 individuals
Mar 2020Rights issue₹6.15 CrInvestors: 4 individuals
Mar 2020Rights issue₹1.3 CrInvestors: 3 individuals
Jan 2020Rights issue₹2.96 CrInvestors: 2 individuals
Mar 2019Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual

To see the full deal history of Admerus Biosciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Admerus Biosciences Private Limited was last rated by Crisil on 06 Dec 2021.

Rating agencyRated onRating
Crisil06 Dec 2021

To see the full credit ratings and regulatory alerts of Admerus Biosciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Admerus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Admerus Biosciences Private Limited has a workforce of 19 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1
Employee growth
72.73%

GST

Admerus Biosciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AANCA5988K1ZUTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Admerus Biosciences Private Limited, buy the company report.

Recent activity

Admerus Biosciences Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Vijay Kumar Raina ceased to be Additional Director on 26 Nov 2023.

Charges
A charge with State Bank Of India amounted to Rs. 4.32 Cr with Charge ID 101097818 was registered on 12 May 2025.
Charges
A charge registered on 17 Nov 2017 via Charge ID 100185075 with State Bank Of India was fully satisfied on 01 Feb 2025.
AGM
Admerus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Admerus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Vijay Kumar Raina ceased to be Additional Director.
Ceased
Sailendrakumar Jagabandhu Goswami ceased to be Ceo(Kmp).
Charges
A charge with State Bank Of India of Rs. 20.95 Cr registered on 17 Nov 2017 with Charge ID 100185075 was modified on 15 Feb 2021.
Ceased
Pattabhi Ram Koppineedi ceased to be Director.
Ceased
Venkata Nageswararao Koppineedi ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 20.95 Cr with Charge ID 100185075 was registered on 17 Nov 2017.
Appointed
Jayasree Koppineedi was appointed as Director.
Appointed
China Gangaiah Koppineedi was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Admerus Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 09 July 2015 (11+ years old) and is registered under CIN U74900TG2015PTC133392.

Admerus Biosciences has 3 current directors:

The latest financial statements of Admerus Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Admerus Biosciences is 36AANCA5988K1ZU, registered in Telangana.

The CIN (Corporate Identification Number) of Admerus Biosciences is U74900TG2015PTC133392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Admerus Biosciences has 4 court cases on record: 2 filed by the company and 2 filed against it. 3 are pending. Most are in the high courts.

Admerus Biosciences was incorporated on 09 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.

Admerus Biosciences has 8 deals on record (4 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.22 Cr; the latest was in December 2022.

Vijay Kumar Raina ceased to be Additional Director on 26 Nov 2023. Sailendrakumar Jagabandhu Goswami ceased to be Ceo(Kmp) on 13 Dec 2022. Pattabhi Ram Koppineedi ceased to be Director on 17 Jul 2020. Admerus Biosciences has 7 board changes on record in total.

Yes, Admerus Biosciences is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0031652).